Patents by Inventor Edward G. Garmey

Edward G. Garmey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER
    Publication number: 20160101185
    Abstract: Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.
    Type: Application
    Filed: May 12, 2015
    Publication date: April 14, 2016
    Applicant: CERULEAN PHARMA INC.
    Inventors: Edward G. Garmey, Scott Eliasof
  • TREATMENT OF CANCER
    Publication number: 20140105891
    Abstract: Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.
    Type: Application
    Filed: October 4, 2013
    Publication date: April 17, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Edward G. Garmey, Scott Eliasof
  • Methods for treatment of non-small cell lung cancer
    Patent number: 8575191
    Abstract: The present invention provides methods of treating non-small cell lung cancer by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound in combination with a therapeutically effective amount of an epidermal growth factor tyrosine kinase inhibitor.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: November 5, 2013
    Assignee: ArQule, Inc.
    Inventors: Yinpu Chen, Edward G. Garmey, Brian Schwartz
  • Methods for Treatment of Non-Small Cell Lung Cancer
    Publication number: 20120052062
    Abstract: The present invention provides methods of treating non-small cell lung cancer by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound in combination with a therapeutically effective amount of an epidermal growth factor tyrosine kinase inhibitor
    Type: Application
    Filed: August 31, 2011
    Publication date: March 1, 2012
    Applicant: ArQule, Inc.
    Inventors: Yinpu Chen, Edward G. Garmey, Brian Schwartz